<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>Reproductive Health - Latest articles</title>
		<link>http://www.reproductive-health-journal.com</link>
		<description>The latest articles from Reproductive Health (ISSN 1742-4755) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.reproductive-health-journal.com/content/5/1/4"/>			    
            
				    <rdf:li rdf:resource="http://www.reproductive-health-journal.com/content/5/1/3"/>			    
            
				    <rdf:li rdf:resource="http://www.reproductive-health-journal.com/content/5/1/2"/>			    
            
				    <rdf:li rdf:resource="http://www.reproductive-health-journal.com/content/5/1/1"/>			    
            
				    <rdf:li rdf:resource="http://www.reproductive-health-journal.com/content/4/1/12"/>			    
            
				    <rdf:li rdf:resource="http://www.reproductive-health-journal.com/content/4/1/11"/>			    
            
				    <rdf:li rdf:resource="http://www.reproductive-health-journal.com/content/4/1/10"/>			    
            
				    <rdf:li rdf:resource="http://www.reproductive-health-journal.com/content/4/1/9"/>			    
            
				    <rdf:li rdf:resource="http://www.reproductive-health-journal.com/content/4/1/8"/>			    
            
				    <rdf:li rdf:resource="http://www.reproductive-health-journal.com/content/4/1/7"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.reproductive-health-journal.com/content/5/1/4">
            
            <title>ICPD to MDGs: Missing links and common grounds</title>
			<description>The ICPD agenda of reproductive health was declared as the most comprehensive one, which had actually broadened the spectrum of reproductive health and drove the states to embark upon initiatives to improve reproductive health status of their populations. However, like all other countries, Pakistan also seems to have shifted focus of its policies and programs towards achieving MDGs. As a result, concepts highlighted in the ICPD got dropped eventually. In spite of specific goals on maternal and child mortalities in MDGs and all the investment and policy shift, Pakistan has still one of the highest maternal mortality ratios among developing countries. Lack of synchronized efforts, sector wide approaches, inter-sectoral collaboration, and moreover, the unmet need for family planning, unsafe abortions, low literacy rate and dearth of women empowerment are the main reasons. Being a signatory of both of the international agendas (ICPD and MDGs), Pakistan needed to articulate its policies to keep the balance between the two agendas. There are, however, certainly some common grounds which have been experimented by various countries and we can learn lessons from those best practices. An inter-sectoral cooperation and sector wide approaches would be required to achieve such ambitious goals set out in ICPD-Program of Action while working towards MDGs. There is a need of increasing resource allocation, strengthening primary health care services and emergency obstetric care and motivating the human resource employed in health sector by good governance. These endeavors should lead to formulate evidence based national policies, reproductive health services which are affordable, accessible and culturally acceptable and finally a responsive health system.</description>
			<link>http://www.reproductive-health-journal.com/content/5/1/4</link>
			
			 	<dc:creator>Farina G Abrejo, Babar T Shaikh and Sarah Saleem</dc:creator>
			
			<dc:source>Reproductive Health 2008, 5:4</dc:source>
			<dc:date>2008-09-10</dc:date>
			<dc:identifier>doi:10.1186/1742-4755-5-4</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Health</prism:publicationName>
					
			
							
					<prism:issn>1742-4755</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>4</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-10</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.reproductive-health-journal.com/content/5/1/3">
            
            <title>Gynaecological morbidity among HIV positive pregnant women in Cameroon</title>
			<description>ObjectiveTo compare the prevalence of gynaecological conditions among HIV infected and non-infected pregnant women.
Methods:
Two thousand and eight (2008) pregnant women were screened for HIV, lower genital tract infections and lower genital tract neoplasia at booking antenatal visit.
Results:
About 10% (198/2008) were HIV positive. All lower genital tract infections except candidiasis were more prevalent among HIV positive compared to HIV negative women: vaginal candidiasis (36.9% vs 35.4%; p = 0.678), Trichomoniasis (21.2% vs 10.6%; p &lt; 0.001), gonorrhoea (10.1% vs 2.5%; p &lt; 0.001), bacterial vaginosis (21.2% vs 15.2%; p = 0.026), syphilis (35.9% vs 10.6%; p &lt; 0.001), and Chlamydia trachomatis (38.4% vs 7.1%; p &lt; 0.001). Similarly, HIV positive women more likely to have preinvasive cervical lesions: low-grade squamous intraepithelial lesion (SIL) (18.2% vs 4.4%; p &lt; 0.001) and high-grade squamous intraepithelial lesion (12.1% vs 1.5%; p &lt; 0.001).
Conclusion:
We conclude that (i) sexually transmitted infections (STIs) are common in both HIV positive and HIV negative pregnant women in Cameroon, and (ii) STIs and preinvasive cervical lesions are more prevalent in HIV-infected pregnant women compared to their non-infected compatriots. We recommend routine screening and treatment of STIs during antenatal care in Cameroon and other countries with similar social profiles.</description>
			<link>http://www.reproductive-health-journal.com/content/5/1/3</link>
			
			 	<dc:creator>Enow R Mbu, Eugene J Kongnyuy, FX Mbopi-Keou, Rebecca N Tonye, Philip N Nana and Robert JI Leke</dc:creator>
			
			<dc:source>Reproductive Health 2008, 5:3</dc:source>
			<dc:date>2008-07-03</dc:date>
			<dc:identifier>doi:10.1186/1742-4755-5-3</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Health</prism:publicationName>
					
			
							
					<prism:issn>1742-4755</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>3</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-03</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.reproductive-health-journal.com/content/5/1/2">
            
            <title>Comparison of two doses and two routes of administration of misoprostol after pre-treatment with mifepristone for early pregnancy termination</title>
			<description>Background:
It is not known whether a 400 &#956;g dose of misoprostol has a similar efficacy as an 800 &#956;g dose when administered sublingually or vaginally 24 hours after 200 mg mifepristone.
Methods:
It is proposed to undertake a placebo-controlled, randomized, non-inferiority trial (3% margin of equivalence) of the two misoprostol doses when administered sublingually or vaginally using factorial design. A total of 3008 pregnant women (&lt; 63 days of gestational age) who request legal termination of pregnancy will be recruited for the trial at 16 clinics in ten countries providing abortion services. Eligible women willing to join the study will be allocated randomly to one of the four treatment groups within each centre. Women in all treatment groups will first receive 200 mg mifepristone, followed 24 hours later by either 400 &#956;g or 800 &#956;g misoprostol, administered either sublingually or vaginally. The dose and route of administration of misoprostol will be blinded to women, each woman receiving four tablets vaginally and four tablets sublingually, two or four of which are 200 &#956;g tablets of misoprostol and the rest are placebo tablets.The four treatment regimens will be compared in terms of: (i) their efficacy to induce complete abortion; (ii) induction-to-abortion interval when possible; (iii) the frequency of side effects; and (iv) women's perceptions. The initial judgment of the outcome of treatment is made at the follow-up visit on day 15 of the study and the final assessment four weeks later. It is estimated that the clinical phase will require 12&#8211;14 months for data collection.To compare the two routes and two doses, relative risks (RR) of failure to achieve a complete abortion and failure to terminate pregnancy and the two-sided 95% CIs will be calculated by standard methods, as well as risk differences and two-sided 95% CIs. The latter will be used to test the non-inferiority hypotheses (at 2.5% level of significance) for achieving complete abortion. The factorial structure will be taken into account in the analysis after testing the interaction.Trial registrationISRCTN87811512</description>
			<link>http://www.reproductive-health-journal.com/content/5/1/2</link>
			
			 	<dc:creator>Helena von Hertzen, Gilda Piaggio and Lena Marions</dc:creator>
			
			<dc:source>Reproductive Health 2008, 5:2</dc:source>
			<dc:date>2008-06-23</dc:date>
			<dc:identifier>doi:10.1186/1742-4755-5-2</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Health</prism:publicationName>
					
			
							
					<prism:issn>1742-4755</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>2</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-23</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.reproductive-health-journal.com/content/5/1/1">
            
            <title>Reproductive health issues in rural Western Kenya</title>
			<description>Background:
We describe reproductive health issues among pregnant women in a rural area of Kenya with a high coverage of insecticide treated nets (ITNs) and high prevalence of HIV (15%).
Methods:
We conducted a community-based cross-sectional survey among rural pregnant women in western Kenya. A medical, obstetric and reproductive history was obtained. Blood was obtained for a malaria smear and haemoglobin level, and stool was examined for geohelminths. Height and weight were measured.
Results:
Of 673 participants, 87% were multigravidae and 50% were in their third trimester; 41% had started antenatal clinic visits at the time of interview and 69% reported ITN-use. Malaria parasitemia and anaemia (haemoglobin &lt; 11 g/dl) were detected among 36% and 53% of the women, respectively. Geohelminth infections were detected among 76% of the 390 women who gave a stool sample. Twenty percent of women were underweight, and sixteen percent reported symptoms of herpes zoster or oral thrush in the last two months. Nineteen percent of all women reported using a contraceptive method to delay or prevent pregnancy before the current pregnancy (injection 10%, pill 8%, condom 0.4%). Twenty-three percent of multigravidae conceived their current pregnancy within a year of the previous pregnancy. More than half of the multigravidae (55%) had ever lost a live born child and 21% had lost their last singleton live born child at the time of interview.
Conclusion:
In this rural area with a high HIV prevalence, the reported use of condoms before pregnancy was extremely low. Pregnancy health was not optimal with a high prevalence of malaria, geohelminth infections, anaemia and underweight. Chances of losing a child after birth were high. Multiple interventions are needed to improve reproductive health in this area.</description>
			<link>http://www.reproductive-health-journal.com/content/5/1/1</link>
			
			 	<dc:creator>Anna M van Eijk, Kim A Lindblade, Frank Odhiambo, Elizabeth Peterson, Evallyne Sikuku, John G Ayisi, Peter Ouma, Daniel H Rosen and Laurence Slutsker</dc:creator>
			
			<dc:source>Reproductive Health 2008, 5:1</dc:source>
			<dc:date>2008-03-18</dc:date>
			<dc:identifier>doi:10.1186/1742-4755-5-1</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Health</prism:publicationName>
					
			
							
					<prism:issn>1742-4755</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>1</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-18</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.reproductive-health-journal.com/content/4/1/12">
            
            <title>A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisation (IVF) treatment: Poor responders intervention trial (PRINT)</title>
			<description>Background:
Poor response to ovarian stimulation with exogenous gonadotrophins occurs in 9&#8211;24% of women undergoing in vitro fertilisation (IVF) treatment, which represents an estimated 4000&#8211;10,000 women per year in the UK. Poor responders often have their treatment cycle cancelled because of expected poor outcome.One treatment strategy that may influence outcome is the choice of pituitary suppression regimen prior to the initiation of ovarian stimulation. The three commonly used pituitary suppression regimens in IVF treatment are:(1) the GnRH agonist long regimen,(2) the GnRH agonist short regimen and(3) the GnRH antagonist regimen.A systematic review of randomised controlled trials of these pituitary suppression regimens has shown the evidence to be either inconclusive or inconsistent. We therefore designed a three arm randomised trial to evaluate the effectiveness of these regimens in women who had poor ovarian response in a previous IVF treatment cycle.Methods/designConsenting, eligible women will be randomised to one of the three regimens using an internet-based trial management programme that ensures allocation concealment and employs block randomisation and minimisation for prognostic variables. The primary outcome is the number of oocytes retrieved. Other outcomes include total dose of follicle stimulating hormone (FSH) used for ovarian stimulation, mature oocytes retrieved, embryos available for transfer, implantation rate and clinical pregnancy rate.The sample size for this trial has been estimated as 102 participants with 34 participants in each of the three arms. Appropriate interim analysis will be conducted by a Data Monitoring and Ethics Committee (DMEC), and the final analysis will be by intention to treat.Trial registrationISRCTN27044628</description>
			<link>http://www.reproductive-health-journal.com/content/4/1/12</link>
			
			 	<dc:creator>Sesh K Sunkara, Arri Coomarasamy, Yakoub Khalaf and Peter Braude</dc:creator>
			
			<dc:source>Reproductive Health 2007, 4:12</dc:source>
			<dc:date>2007-12-28</dc:date>
			<dc:identifier>doi:10.1186/1742-4755-4-12</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Health</prism:publicationName>
					
			
							
					<prism:issn>1742-4755</prism:issn>
					
			
							
					<prism:volume>4</prism:volume>
					
			
							
					<prism:startingPage>12</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-12-28</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.reproductive-health-journal.com/content/4/1/11">
            
            <title>A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants</title>
			<description>Background:
The aim of this study was to evaluate bone mineral density (BMD) at baseline and at 18 and 36 months of use of etonogestrel (ENG)-and levonorgestrel (LNG)-releasing contraceptive implants. This is a continuation of a previous study in which BMD was evaluated at baseline and at 18 months of use.
Methods:
A total of 111 women, 19&#8211;43 years of age, wererandomly allocated to use one of the two implants. At 36 months of follow-up, only 36 and 39 women were still using the ENG- and LNG-releasing implants, respectively. BMD was evaluated at the distal and at the ultra-distal radius of the non-dominant forearm using dual-energy X-ray absorptiometry.
Results:
There was no difference in the BMD of users of either implant at 18 and at 36 months. BMD was significantly lower at 18 and at 36 months at the distal radius in both groups of users compared to pre-insertion values; however, no difference was found at the ultra-distal radius.
Conclusion:
Women 19&#8211;43 years of age using either one of these two contraceptive implants for 36 months had lower BMD values at the distal radius compared to pre-insertion values; however, no difference was found at the ultra-distal radius.</description>
			<link>http://www.reproductive-health-journal.com/content/4/1/11</link>
			
			 	<dc:creator>Cecilia Monteiro-Dantas, Ximena Espejo-Arce, Jeffrey F Lui-Filho, Arlete M Fernandes, Ilza Monteiro and Luis Bahamondes</dc:creator>
			
			<dc:source>Reproductive Health 2007, 4:11</dc:source>
			<dc:date>2007-11-12</dc:date>
			<dc:identifier>doi:10.1186/1742-4755-4-11</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Health</prism:publicationName>
					
			
							
					<prism:issn>1742-4755</prism:issn>
					
			
							
					<prism:volume>4</prism:volume>
					
			
							
					<prism:startingPage>11</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-11-12</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.reproductive-health-journal.com/content/4/1/10">
            
            <title>The outcomes of midline versus medio-lateral episiotomy</title>
			<description>Background:
Episiotomy is the surgical enlargement of the vaginal orifice by an incision of the perineum during the second stage of labor or just before delivery of the baby. During the 1970s, it was common to perform an episiotomy for almost all women having their first delivery, ostensibly for prevention of severe perineum tears and easier subsequent repair. However, there are no data available to indicate if an episiotomy should be midline or medio-lateral. We compared midline versus medio-lateral episiotomy for complication such as extended perineal tears, pain scores, wound infection rates and other complications.
Methods:
We conducted a prospective cohort including 1,302 women, who gave birth vaginally between April 2005 and February 2006 at Srinagarind Hospital &#8211; a tertiary care center in Northeast Thailand. All women included had low risk pregnancies and delivered at term. The outcome measures included deep perineal tears (including perineal tears with anal sphincter and/or rectum tears), other complications, and women's satisfaction at 48 hours and 6-weeks postpartum.
Results:
In women with midline episiotomy, deep perineal tears occurred in 14.8%, which is statistically significantly higher compared to 7% in women who underwent a medio-lateral episiotomy (p-value &lt; 0.05). There was no difference between the groups for other outcomes (such as blood loss, vaginal hematoma, infection, pain, dyspareunia, and women's satisfaction with the method). The risk factors for deep perineal tears were: midline episiotomy, primiparity, maternal height &lt; 145 cm, fetal birth weight > 3,500 g and forceps extraction.
Conclusion:
Midline compared to medio-lateral episiotomy resulted in more deep perineal tears. It is more likely deep perineal tears would occur in cases with additional risk factors.</description>
			<link>http://www.reproductive-health-journal.com/content/4/1/10</link>
			
			 	<dc:creator>Ratchadawan Sooklim, Jadsada Thinkhamrop, Pisake Lumbiganon, Witoon Prasertcharoensuk, Jeerichuda Pattamadilok, Kanok Seekorn, Chompilas Chongsomchai, Prakai Pitak and Sukanya Chansamak</dc:creator>
			
			<dc:source>Reproductive Health 2007, 4:10</dc:source>
			<dc:date>2007-10-29</dc:date>
			<dc:identifier>doi:10.1186/1742-4755-4-10</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Health</prism:publicationName>
					
			
							
					<prism:issn>1742-4755</prism:issn>
					
			
							
					<prism:volume>4</prism:volume>
					
			
							
					<prism:startingPage>10</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-10-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.reproductive-health-journal.com/content/4/1/9">
            
            <title>Middle Eastern mothers in Sweden, their experiences of the maternal health service and their partner's involvement</title>
			<description>Background:
Traditional patterns relating to how to handle pregnancy and birth are often challenged due to migration. The purpose of this study was to describe Middle Eastern mothers' experiences of the maternal health care services in Sweden and the involvement of their male partner.
Methods:
Thirteen immigrant mothers from the Middle East who had used the maternal health services in Sweden were interviewed using focus group discussions and individual interviews. These were taped, transcribed and analysed according to Content analysis.
Results:
The four main categories that developed were:&#8226; Access to the professional midwife&#8226; Useful counselling&#8226; Stable motherhood in transition&#8226; Being a family living in a different culture
Conclusion:
According to the respondents in this study, understanding the woman's native language or her culture was not vital to develop a good relationship with the midwife. Instead the immigrant woman developed trust in the midwife based on the knowledge and the empathy the midwife imparted.Increasing the amount of first trimester antenatal visits could avoid spontaneous visits to the emergency clinic. There was a greater need for involvement and support by the father during the perinatal period, such as caring for older children and carrying out household chores since the mothers' earlier female network was often lost.Clinical implicationsThere is a need to involve immigrant parents in the available parental education in order to prepare them for parenthood in their new country as well as to explore their altered family situation. Collecting immigrant women and their partner's, experiences of maternal health care services offers a possibility to improve the existing care, both in content, access and availability where the timing of visits and content require further evaluation.</description>
			<link>http://www.reproductive-health-journal.com/content/4/1/9</link>
			
			 	<dc:creator>Pernilla Ny, Lars Plantin, Elisabeth D Karlsson and Anna-Karin Dykes</dc:creator>
			
			<dc:source>Reproductive Health 2007, 4:9</dc:source>
			<dc:date>2007-10-24</dc:date>
			<dc:identifier>doi:10.1186/1742-4755-4-9</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Health</prism:publicationName>
					
			
							
					<prism:issn>1742-4755</prism:issn>
					
			
							
					<prism:volume>4</prism:volume>
					
			
							
					<prism:startingPage>9</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-10-24</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.reproductive-health-journal.com/content/4/1/8">
            
            <title>Antenatal screening and the gendering of genetic responsibility</title>
			<description>Background:
The objective of this study is to explore men's and women's perceptions of antenatal blood screening. The study will assess the impact of these perceptions on decision-making regarding diagnostic testing and selective abortion, and on parental feelings of genetic responsibility. By exploring gender and antenatal screening in this way, the research aims to contribute to our understanding of lay perceptions of genetic screening and increase our knowledge of the decision-making process in screening.Research designThis qualitative study will be based on semi-structured interviews with twenty pregnant women and twenty male partners in the post-industrial city of Sheffield, UK. All interviews will be taped, transcribed and analysed thematically using NVIVO, a qualitative software package.DiscussionThe findings of this study have relevance to existing debates on the social and ethical implications of reproductive genetics. A better understanding of male and female perceptions of the screening process could improve guidance and practice in antenatal screening and genetic counselling. It will also inform and contribute to the development of theory on gender and genetic screening.</description>
			<link>http://www.reproductive-health-journal.com/content/4/1/8</link>
			
			 	<dc:creator>Kate Reed</dc:creator>
			
			<dc:source>Reproductive Health 2007, 4:8</dc:source>
			<dc:date>2007-09-28</dc:date>
			<dc:identifier>doi:10.1186/1742-4755-4-8</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Health</prism:publicationName>
					
			
							
					<prism:issn>1742-4755</prism:issn>
					
			
							
					<prism:volume>4</prism:volume>
					
			
							
					<prism:startingPage>8</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-09-28</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.reproductive-health-journal.com/content/4/1/7">
            
            <title>Delays in seeking an abortion until the second trimester: a qualitative study in South Africa</title>
			<description>Background:
Despite changes to the South African abortion legislation in 1996, barriers to women accessing abortions still exist. Second trimester abortions, an inherently more risky procedure, continue to be 20% of all abortions. Understanding the reasons why women delay seeking an abortion until the second trimester is important for informing interventions to reduce the proportion of second trimester abortions in South Africa.
Methods:
Qualitative research methods were used to collect data. Twenty-seven in-depth interviews were conducted in 2006 with women seeking a second trimester abortion at one public sector tertiary hospital and two NGO health care facilities in the greater Cape Town area, South Africa. Data were analysed using a grounded theory approach.
Results:
Almost all women described multiple and interrelated factors that influenced the timing of seeking an abortion. Reasons why women delayed seeking an abortion were complex and were linked to changes in personal circumstances often leading to indecision, delays in detecting a pregnancy and health service related barriers that hindered access to abortion services.
Conclusion:
Understanding the complex reasons why women delay seeking an abortion until the second trimester can inform health care interventions aimed at reducing the proportion of second trimester abortions in South Africa.</description>
			<link>http://www.reproductive-health-journal.com/content/4/1/7</link>
			
			 	<dc:creator>Jane Harries, Phyllis Orner, Mosotho Gabriel and Ellen Mitchell</dc:creator>
			
			<dc:source>Reproductive Health 2007, 4:7</dc:source>
			<dc:date>2007-09-20</dc:date>
			<dc:identifier>doi:10.1186/1742-4755-4-7</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Health</prism:publicationName>
					
			
							
					<prism:issn>1742-4755</prism:issn>
					
			
							
					<prism:volume>4</prism:volume>
					
			
							
					<prism:startingPage>7</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-09-20</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
